Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19247755 | METHODS AND SYSTEMS FOR INSULIN DELIVERY AND GLUCOSE MEASUREMENT | June 2025 | August 2025 | Allow | 2 | 1 | 0 | No | No |
| 19247768 | METHODS AND SYSTEMS FOR INSULIN DELIVERY AND GLUCOSE MEASUREMENT | June 2025 | December 2025 | Allow | 6 | 1 | 0 | No | No |
| 19175750 | SYSTEMS AND METHODS FOR DELIVERING A FLUID TO A PATIENT WITH REDUCED CONTAMINATION | April 2025 | May 2025 | Allow | 1 | 0 | 0 | No | No |
| 19022929 | RADIOPHARMACEUTICAL DELIVERY SYSTEM FOR PATIENT INFUSION | January 2025 | May 2025 | Allow | 4 | 1 | 0 | No | No |
| 18985633 | Auto-Injector | December 2024 | March 2025 | Allow | 3 | 0 | 0 | No | No |
| 18985292 | Auto-Injector | December 2024 | March 2025 | Allow | 3 | 0 | 0 | No | No |
| 18986595 | Auto-Injector | December 2024 | March 2025 | Allow | 3 | 0 | 0 | No | No |
| 18982635 | Auto-Injector | December 2024 | April 2025 | Allow | 4 | 1 | 0 | No | No |
| 18982446 | Auto-Injector | December 2024 | April 2025 | Allow | 4 | 1 | 0 | No | No |
| 18983179 | Auto-Injector | December 2024 | April 2025 | Allow | 4 | 1 | 0 | No | No |
| 18907846 | METHODS AND SYSTEMS FOR INSULIN DELIVERY AND GLUCOSE MEASUREMENT | October 2024 | April 2025 | Allow | 6 | 1 | 1 | No | No |
| 18896045 | SITE TRACKING BASED ON CONNECTIVITY IN INFUSION PUMP SYSTEMS | September 2024 | September 2025 | Allow | 11 | 1 | 0 | Yes | No |
| 18819145 | RADIOPHARMACEUTICAL DELIVERY SYSTEM AND USE THEREOF FOR PATIENT INFUSION | August 2024 | December 2024 | Allow | 3 | 1 | 0 | No | No |
| 18779971 | INFUSION PUMP ASSEMBLY AND METHOD | July 2024 | May 2025 | Allow | 9 | 1 | 0 | No | No |
| 18764688 | INTEGRATED INSULIN DELIVERY SYSTEM HAVING SAFETY FEATURES TO PREVENT HYPOGLYCEMIA | July 2024 | March 2026 | Allow | 20 | 3 | 1 | Yes | No |
| 18653050 | TIME AVERAGED BASAL RATE OPTIMIZER | May 2024 | July 2024 | Allow | 2 | 0 | 0 | No | No |
| 18618798 | IMPROVED RADIOPHARMACEUTICAL DELIVERY SYSTEM AND USE THEREOF FOR PATIENT INFUSION | March 2024 | August 2024 | Allow | 4 | 0 | 0 | No | No |
| 18616200 | BLOOD REGURGITATION PREVENTING PUNCTURE AND GUIDANCE DEVICE WITHOUT SKIN DILATION | March 2024 | June 2024 | Allow | 3 | 0 | 0 | No | No |
| 18432297 | ANESTHETIC NERVE BLOCK AND METHOD | February 2024 | April 2024 | Allow | 2 | 0 | 0 | No | No |
| 18399007 | SYSTEMS AND METHODS FOR DELIVERING A FLUID TO A PATIENT WITH REDUCED CONTAMINATION | December 2023 | June 2024 | Allow | 6 | 1 | 0 | No | No |
| 18489322 | PERITONSILLAR ABSCESS ASPIRATION KIT AND METHOD OF USE | October 2023 | August 2024 | Allow | 10 | 2 | 0 | Yes | No |
| 18374816 | METHODS, SYSTEMS, AND APPARATUS FOR ADMINISTERING AN ANTIBODY TREATMENT VIA INFUSION | September 2023 | July 2024 | Allow | 10 | 1 | 1 | No | No |
| 18367164 | TIME AVERAGED BASAL RATE OPTIMIZER | September 2023 | November 2023 | Allow | 2 | 1 | 0 | Yes | No |
| 18341879 | Medicament Container Holder | June 2023 | October 2025 | Allow | 28 | 1 | 0 | No | No |
| 18212596 | SYSTEMS AND METHODS FOR DETECTING DISRUPTIONS IN FLUID DELIVERY DEVICES | June 2023 | February 2026 | Allow | 32 | 0 | 0 | No | No |
| 18208858 | BRAIDED CATHETER ASSEMBLIES | June 2023 | February 2025 | Allow | 20 | 0 | 0 | No | No |
| 18208414 | APPARATUS AND METHOD FOR INFUSING FLUID THROUGH A TUBE BY APPROPRIATELY HEATING THE TUBE | June 2023 | July 2025 | Allow | 25 | 1 | 0 | No | No |
| 18331496 | SONOTRODE | June 2023 | November 2025 | Allow | 29 | 2 | 0 | No | No |
| 18330785 | Acoustic Detection of a Usage of an Injection Device | June 2023 | April 2025 | Allow | 22 | 4 | 0 | Yes | No |
| 18324510 | ELECTROSURGICAL SYSTEM | May 2023 | January 2025 | Allow | 20 | 0 | 0 | No | No |
| 18254586 | CASSETTE FOR RETENTION OF FLUID PATH COMPONENTS FOR FLUID INJECTOR SYSTEM | May 2023 | March 2024 | Allow | 10 | 1 | 0 | No | No |
| 18317968 | PRESSURE ACTIVATED VALVE FOR HIGH FLOW RATE AND PRESSURE VENOUS ACCESS APPLICATIONS | May 2023 | July 2025 | Abandon | 27 | 1 | 0 | No | No |
| 18144555 | Auto-Injector | May 2023 | August 2023 | Allow | 3 | 0 | 0 | No | No |
| 18144043 | ANESTHETIC NERVE BLOCK AND METHOD | May 2023 | July 2023 | Allow | 2 | 0 | 0 | No | No |
| 18137830 | EXPANDABLE SHEATH FOR INTRODUCING AN ENDOVASCULAR DELIVERY DEVICE INTO A BODY | April 2023 | December 2025 | Allow | 31 | 0 | 0 | No | No |
| 18136278 | SYSTEMS AND METHODS FOR AUTOMATED INSULIN DELIVERY FOR DIABETES THERAPY | April 2023 | April 2025 | Allow | 24 | 1 | 0 | No | No |
| 18031976 | METHOD AND SYSTEM OF CLOSED LOOP CONTROL IMPROVING GLYCEMIC RESPONSE FOLLOWING AN UNANNOUNCED SOURCE OF GLYCEMIC FLUCTUATION | April 2023 | January 2026 | Allow | 33 | 0 | 0 | No | No |
| 18119062 | ADJUSTING MEDICAMENT DELIVERY PARAMETERS IN AN OPEN LOOP MEDICAMENT DELIVERY MODE | March 2023 | October 2025 | Allow | 32 | 0 | 0 | No | No |
| 18114332 | LIQUID MEDICINE INJECTION DEVICE, DRUG INJECTION DEVICE, AND METHOD FOR DETERMINING REMAINING AMOUNT OF DRUG THEREOF | February 2023 | July 2025 | Allow | 29 | 0 | 0 | No | No |
| 18163244 | Systems, Devices, and Methods for Blood Pressure Control | February 2023 | February 2026 | Allow | 36 | 0 | 0 | No | No |
| 18018206 | Arrangement for a drug delivery device | January 2023 | October 2025 | Allow | 32 | 0 | 0 | No | No |
| 18100052 | PATCH-SIZED FLUID DELIVERY SYSTEMS AND METHODS | January 2023 | March 2025 | Allow | 26 | 1 | 0 | No | No |
| 18155978 | MODULAR WEARABLE DEVICE FOR PATIENT MONITORING AND DRUG ADMINISTRATION | January 2023 | March 2026 | Allow | 37 | 1 | 0 | No | No |
| 18064969 | Two-Stage Reconstituting Injector | December 2022 | May 2025 | Abandon | 29 | 1 | 0 | Yes | No |
| 18071814 | SYSTEM AND METHOD OF MODIFYING USER PROFILE IN AUTOMATED INSULIN DELIVERY | November 2022 | March 2026 | Allow | 39 | 1 | 0 | No | No |
| 17985638 | SYSTEMS AND METHODS FOR DETECTING DISRUPTIONS IN FLUID DELIVERY DEVICES | November 2022 | November 2025 | Allow | 36 | 0 | 0 | No | No |
| 17998474 | Wearable Device for Transdermal Product Supply | November 2022 | October 2025 | Allow | 35 | 0 | 0 | No | No |
| 17924210 | UMBILICAL ANCHOR SYSTEM | November 2022 | March 2026 | Abandon | 40 | 1 | 0 | No | No |
| 18048931 | FLUID INJECTOR SYSTEM VOLUME COMPENSATION SYSTEM AND METHOD | October 2022 | October 2024 | Allow | 23 | 0 | 0 | No | No |
| 18046785 | COMPENSATION OF PRESSURE DRIVEN LEAKAGE WHILE USING HIGH PRECISION VOLUMETRIC PUMPS | October 2022 | July 2025 | Allow | 33 | 0 | 0 | No | No |
| 17916602 | Pre-Filled Syringe System and Method | October 2022 | November 2025 | Allow | 37 | 1 | 0 | No | No |
| 17937514 | SANITIZING CAPS FOR MEDICAL CONNECTORS | October 2022 | June 2025 | Allow | 32 | 1 | 0 | No | No |
| 17957396 | NASAL DRUG DELIVERY APPARATUS AND METHODS OF USE | September 2022 | January 2025 | Allow | 28 | 1 | 0 | No | No |
| 17913108 | SYSTEMS AND METHODS FOR A DATA DRIVEN FRAMEWORK FOR ACTIONABLE FEEDBACK IN INSULIN MANAGEMENT FOR TYPE 1 DIABETIC SUBJECTS ON ARTIFICIAL PANCREAS | September 2022 | July 2025 | Allow | 34 | 0 | 0 | No | No |
| 17947130 | ULTRASONIC URINARY BLADDER DRUG DELIVERY | September 2022 | August 2025 | Allow | 35 | 0 | 0 | No | No |
| 17902365 | INFUSION PUMP ALIGNMENT FEATURES FOR VERTICALLY-ORIENTATED IV TUBES | September 2022 | September 2024 | Allow | 25 | 0 | 0 | No | No |
| 17929169 | Dosage Verification System and Method for Safety Syringe | September 2022 | August 2025 | Allow | 36 | 3 | 1 | No | No |
| 17896327 | MEDICAL DEVICE HAVING COMMMUNICATION FUNCTION AND COMMUNICATION SYSTEM | August 2022 | November 2025 | Allow | 39 | 1 | 0 | No | No |
| 17820381 | SELF-ORIENTING SYRINGE AND SYRINGE INTERFACE | August 2022 | June 2025 | Allow | 34 | 0 | 0 | No | No |
| 17816839 | MEDICAL CONNECTORS | August 2022 | October 2025 | Allow | 39 | 1 | 0 | No | No |
| 17878832 | ANESTHESIA APPLICATORS/INJECTORS FOR DENTAL AND OTHER APPLICATIONS AND METHODS OF USE | August 2022 | April 2025 | Abandon | 32 | 1 | 0 | No | No |
| 17814703 | A TOLERABLE AND MINIMALLY INVASIVE SKIN ELECTROPORATION DEVICE | July 2022 | August 2025 | Allow | 36 | 2 | 0 | No | No |
| 17870761 | NASAL DEVICE WITH AIR FILTER | July 2022 | May 2025 | Allow | 34 | 1 | 0 | No | No |
| 17860817 | TREATMENT SYSTEM, CONTROL DEVICE, CONTROL METHOD, IMAGE DETERMINATION APPARATUS, AND IMAGE DETERMINATION METHOD | July 2022 | March 2026 | Allow | 44 | 2 | 0 | No | No |
| 17856253 | Auto-Injector | July 2022 | October 2022 | Allow | 3 | 0 | 0 | No | No |
| 17851608 | KEEP VEIN OPEN INFUSION FLOW CONTROL DEVICE | June 2022 | March 2025 | Allow | 32 | 1 | 0 | No | No |
| 17788206 | CONNECTING DEVICE | June 2022 | May 2025 | Allow | 35 | 0 | 0 | No | No |
| 17840423 | METHODS, SYSTEMS, AND APPARATUS FOR ADMINISTERING AN ANTIBODY TREATMENT VIA INFUSION | June 2022 | June 2023 | Allow | 12 | 1 | 1 | No | No |
| 17784418 | PUMPS WITH ORIENTATION INDEPENDENT LIQUID DRUG ACCESSIBILITY | June 2022 | January 2026 | Abandon | 43 | 1 | 0 | No | No |
| 17783362 | LIGHT-DIFFUSING ELEMENT CONFIGURED TO AFFECT THROMBI FORMATION ON INTRAVENOUS CATHETER | June 2022 | December 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17751020 | INTEGRATED MEDICAMENT DELIVERY DEVICE FOR USE WITH CONTINUOUS ANALYTE SENSOR | May 2022 | April 2025 | Allow | 35 | 1 | 0 | No | No |
| 17739589 | Infusion Unit | May 2022 | October 2025 | Allow | 42 | 2 | 0 | No | No |
| 17738500 | SYSTEM AND METHOD FOR INFUSION SET DISLODGEMENT DETECTION | May 2022 | February 2026 | Allow | 46 | 1 | 0 | No | No |
| 17734481 | MEDICAL DEVICE DISPOSABLES INFORMATION SYSTEMS AND METHODS | May 2022 | October 2025 | Allow | 42 | 1 | 0 | No | No |
| 17725376 | INTEGRATED MEDICAMENT DELIVERY DEVICE FOR USE WITH CONTINUOUS ANALYTE SENSOR | April 2022 | July 2025 | Allow | 39 | 0 | 0 | No | No |
| 17719441 | Auto-Injector | April 2022 | February 2025 | Allow | 34 | 1 | 0 | No | No |
| 17716991 | DEVICES AND METHODS FOR TREATING ACUTE KIDNEY INJURY | April 2022 | February 2025 | Abandon | 34 | 1 | 0 | No | No |
| 17657612 | AMBULATORY MEDICAMENT PUMP VOICE OPERATION | March 2022 | October 2022 | Allow | 6 | 0 | 1 | No | No |
| 17655532 | INFUSION SYSTEM AND COMPONENTS THEREOF | March 2022 | August 2024 | Allow | 29 | 1 | 0 | No | No |
| 17698135 | MINIMALLY INVASIVE DERMAL ELECTROPORATION DEVICE | March 2022 | November 2024 | Allow | 32 | 1 | 0 | No | No |
| 17698107 | CONNECTOR FOR MEDICATION DELIVERY SYSTEM | March 2022 | August 2025 | Allow | 41 | 2 | 0 | No | No |
| 17689509 | INTEGRATED MEDICAMENT DELIVERY DEVICE FOR USE WITH CONTINUOUS ANALYTE SENSOR | March 2022 | September 2025 | Allow | 43 | 1 | 0 | No | No |
| 17685170 | AMBULATORY MEDICAMENT DEVICE WITH POWER SAVING MODE | March 2022 | September 2022 | Allow | 7 | 0 | 1 | No | No |
| 17653116 | AMBULATORY MEDICAMENT PUMP WITH SAFE ACCESS CONTROL | March 2022 | June 2022 | Allow | 3 | 0 | 0 | No | No |
| 17673989 | BLADDER FOR AN INFUSION ASSEMBLY | February 2022 | September 2024 | Allow | 31 | 1 | 0 | No | No |
| 17650747 | SYSTEMS AND METHODS FOR APPLYING MEDIA TO SKIN | February 2022 | February 2023 | Allow | 12 | 1 | 1 | No | No |
| 17650430 | Device for a Medicament Container | February 2022 | November 2024 | Allow | 33 | 1 | 0 | No | No |
| 17589068 | METHODS, SYSTEMS, AND APPARATUS FOR ADMINISTERING A MONOCLONAL AND/OR POLYCLONAL ANTIBODY TREATMENT VIA RAPID INFUSION | January 2022 | August 2023 | Allow | 18 | 2 | 1 | Yes | No |
| 17549404 | INSULIN PUMP HAVING BASAL RATE TESTING FEATURES | December 2021 | July 2024 | Allow | 31 | 0 | 0 | No | No |
| 17536911 | DEVICES AND METHODS FOR FLUID DISTRIBUTION FROM A CATHETER | November 2021 | November 2025 | Allow | 47 | 1 | 1 | No | No |
| 17454041 | MEDICAL DEVICES FOR FLUID DELIVERY | November 2021 | May 2024 | Allow | 30 | 0 | 0 | No | No |
| 17453801 | Electrically-Responsive Hydrogels | November 2021 | May 2024 | Allow | 31 | 0 | 0 | No | No |
| 17513487 | INTEGRATED INSULIN DELIVERY SYSTEM HAVING SAFETY FEATURES TO PREVENT HYPOGLYCEMIA | October 2021 | November 2024 | Allow | 37 | 1 | 0 | Yes | No |
| 17509638 | APPARATUS FOR PUMPING AND DIALYSIS | October 2021 | May 2024 | Abandon | 31 | 2 | 0 | No | No |
| 17491949 | Multi-Cartridge Fluid Delivery Device | October 2021 | January 2025 | Allow | 39 | 1 | 0 | No | No |
| 17486784 | AMBULATORY MEDICAMENT DEVICE WITH SECURITY OVERRIDE PASSCODE | September 2021 | June 2024 | Allow | 33 | 1 | 0 | No | No |
| 17479305 | MULTI-CHANNEL AUTOMATIC PUMP | September 2021 | June 2023 | Allow | 21 | 0 | 0 | No | No |
| 17476877 | Multi-Lumen Tamper Tube | September 2021 | December 2024 | Allow | 39 | 3 | 0 | No | No |
| 17475202 | ENHANCED FLEXIBILITY NEUROVASCULAR CATHETER | September 2021 | September 2022 | Allow | 12 | 2 | 0 | No | No |
| 17465653 | SYSTEMS AND METHODS FOR PROTECTING UMBILICAL STUMPS | September 2021 | October 2024 | Abandon | 38 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner FLICK, JASON E.
With a 20.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 35.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner FLICK, JASON E works in Art Unit 3783 and has examined 427 patent applications in our dataset. With an allowance rate of 91.8%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 30 months.
Examiner FLICK, JASON E's allowance rate of 91.8% places them in the 77% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.
On average, applications examined by FLICK, JASON E receive 1.33 office actions before reaching final disposition. This places the examiner in the 19% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by FLICK, JASON E is 30 months. This places the examiner in the 62% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a +7.3% benefit to allowance rate for applications examined by FLICK, JASON E. This interview benefit is in the 36% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 37.8% of applications are subsequently allowed. This success rate is in the 87% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 46.4% of cases where such amendments are filed. This entry rate is in the 70% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 77% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 68.8% of appeals filed. This is in the 55% percentile among all examiners. Of these withdrawals, 36.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 50.7% are granted (fully or in part). This grant rate is in the 50% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.
Examiner's Amendments: This examiner makes examiner's amendments in 0.7% of allowed cases (in the 64% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.